Literature DB >> 14999943

Treatment options for functional abdominal pain.

Colin D Rudolph1, Adrian Miranda.   

Abstract

The successful treatment of pediatric FBD begins during the initial interaction among the patient, family, and physician. It is important that the physician establish a trusting relationship with the family. An early introduction of the concept of functional pain in the differential diagnosis avoids later problems convincing the family that further diagnostic testing is unnecessary. If diagnostic testing is warranted to exclude an organic disorder, it is useful to explain that these tests are being performed to rule out disorders that can present similarly to FBD. Thus, the patient and family recognize that the most likely diagnosis is FBD, and treatment can begin following negative testing. Physicians must account for the role of psychosocial and medical factors that contribute to the expression of illness so as to optimize diagnosis and care. Exploration into the child's psychosocial history can identify a comorbid condition such as anxiety or depression and help guide, specific therapy with psychological interventions, medication, or both. In cases where the abdominal pain is affecting the child's activities of daily living, such as school performance, referral to a psychologist skilled in the use of techniques such as cognitive behavioral therapy may be useful. Symptom-directed pharmacologic therapy can be useful in selected cases.

Entities:  

Mesh:

Year:  2004        PMID: 14999943     DOI: 10.3928/0090-4481-20040201-09

Source DB:  PubMed          Journal:  Pediatr Ann        ISSN: 0090-4481            Impact factor:   1.132


  2 in total

1.  Effect of Traditional Japanese Medicine, Daikenchuto (TJ-100) in Patients With Chronic Constipation.

Authors:  Akira Horiuchi; Yoshiko Nakayama; Naoki Tanaka
Journal:  Gastroenterology Res       Date:  2010-07-20

2.  Understanding and managing children's recurrent pain in primary care: A biopsychosocial perspective.

Authors:  Carl L von Baeyer
Journal:  Paediatr Child Health       Date:  2007-02       Impact factor: 2.253

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.